Definition
Bromoureide designates a class of organic compounds that contain a bromine atom covalently attached to a ureide (carbamide) moiety. Historically, many bromoureides have been employed as central‑acting sedative‑hypnotic agents, particularly in the early to mid‑20th century.
Overview
Bromoureides are structurally related to the ureide family of compounds, which are derivatives of urea (NH₂‑CO‑NH₂). The incorporation of a bromine substituent generally increases the lipophilicity of the molecule, influencing its central nervous system activity. The most well‑known bromoureide is bromisoval (bromovalerylurea), first introduced in the 1900s as a non‑barbiturate hypnotic. Other members include carbromal (N‑(carboxymethyl)‑2‑bromo‑3‑methylbutanamide) and acecarbromal (acetyl‑carbromal). These agents were marketed primarily as over‑the‑counter sleep aids and antispasmodics before concerns about toxicity and dependence limited their use.
Etymology / Origin
The term combines “bromo‑,” referring to the presence of bromine, with “‑ureide,” denoting the ureide functional group derived from urea. The word thus literally means “bromine‑containing ureide.” The classification arose in medicinal chemistry literature of the early 20th century to differentiate these brominated sedatives from other non‑brominated ureide compounds.
Characteristics
| Property | Typical Features |
|---|---|
| Chemical Structure | Core ureide (R‑NH‑CO‑NH‑R′) with one or more bromine atoms attached to carbon atoms adjacent to the carbonyl group. |
| Physical State | Generally crystalline solids at room temperature; modestly soluble in water, more soluble in organic solvents (e.g., ethanol). |
| Pharmacology | Produce sedative‑hypnotic effects by depressing central nervous system activity, likely through enhancement of GABAergic transmission, though the precise mechanism differs from barbiturates. |
| Therapeutic Use | Historically used as sleep aids, mild anxiolytics, and antispasmodics. |
| Adverse Effects | Possible toxicity includes bromism (chronic bromine poisoning), liver dysfunction, and dependence. Overdose can lead to respiratory depression and coma. |
| Regulatory Status | Most bromoureides have been withdrawn or heavily regulated in many countries due to safety concerns; a few remain available in limited formulations in certain jurisdictions. |
Related Topics
- Ureides – a broader class of compounds derived from urea, encompassing many pharmacologically active agents.
- Barbiturates – another class of central nervous system depressants, historically compared with bromoureides.
- Bromism – a condition caused by excessive bromine exposure, relevant to chronic bromoureide use.
- Sedative‑hypnotic drugs – the pharmacological category that includes bromoureides, benzodiazepines, and non‑benzodiazepine sleep agents.
- Carbromal and Acecarbromal – specific bromoureide derivatives with distinct pharmacokinetic profiles.
Note: While the term “bromoureide” appears in pharmacological and chemical literature, comprehensive modern encyclopedic coverage is limited. The information presented reflects data that has been documented in historical sources and pharmacology texts.